OpenClinica, Athena partner to provide clinical trial support in China

Thursday, August 25, 2011

OpenClinica has entered into a strategic alliance with Athena Healthcare Consultancy to bring the OpenClinica clinical trials software to the Chinese market. Headquartered in Shanghai, Athena will be the exclusive distributor of the OpenClinica enterprise edition and provide localized support and services for contract research organizations, pharmaceutical companies, and scientific institutes operating in China, according to Digital Journal.

[Read More]

Singapore develops its first cancer drug

Thursday, March 17, 2011

Singapore has developed its first cancer drug, SB-939, from two Singapore-based cancer institutes and a biotechnology company, S*BIO, according to Channel News Asia.   The Singapore National University Cancer Institute, the Cancer Institute of Singapore and S*BIO have collaborated for the phase I trials.

[Read More]